Key result
Phytosterols plus phospholipids cut total cholesterol and ApoB versus phytosterols alone in borderline hyperlipidemia.
Why the study?
Does combined phytosterols and phospholipids improve blood lipids and erythrocyte membrane profiles in individuals with borderline hyperlipidemia?
Does combined phytosterols and phospholipids improve blood lipids and erythrocyte membrane profiles in individuals with borderline hyperlipidemia?
Combined phytosterols and phospholipids significantly decrease total cholesterol and ApoB in individuals with borderline hyperlipidemia over 60 days.
After a 60-day intervention, TC and ApoB decreased significantly in the combined PSs–PLs group, and TC decreased in the PSs-only group. Erythrocyte lipidomics showed associations with blood lipids and membrane lipids.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question. Combined phytosterols and phospholipids significantly decreased total cholesterol and ApoB in individuals with borderline hyperlipidemia after a 60-day intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: